Claudine Duvivier

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Antonella Castagna, Franco Maggiolo, Giovanni Penco et al. · The Journal of Infectious Diseases · 2014 · 329 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

Christophe Piketty, Hana Selinger‐Leneman, Sophie Grabar et al. · AIDS · 2008 · 282 citations

Medicine, Oncology, Cancer Epidemiology +13

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

Claudine Duvivier, S. Kolta, Lambert Assoumou et al. · AIDS · 2009 · 237 citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Incidence of HIV-Related Anal Cancer Remains Increased Despite Long-Term Combined Antiretroviral Treatment: Results From the French Hospital Database on HIV

Christophe Piketty, Hana Selinger‐Leneman, Anne‐Marie Bouvier et al. · Journal of Clinical Oncology · 2012 · 168 citations · Full text

Medicine, Infectious Diseases, Oncology +17

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136

Christine Katlama, Marc Antoine Valantin, Michèle Algarté-Génin et al. · AIDS · 2010 · 164 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17